Comparisons of early antigens (EA) of EBV-related lymphotropic herpes virus of Old World primates have proved difficult to accomplish because antigen levels are low in infected cells and the ratio of virus capsid antigen to EA is generally high. To overcome these difficulties, we have developed a procedure which combines antigen stimulation with inhibition of late virus functions and results in the selective stimulation of EA. Using this procedure, we have examined the EA of EBV, herpesvirus papio, h. pongo, and h. pan. The results show that the EA of these viruses are composed of both R (restricted) and D (diffuse) components and that the EA, while related, are distinguishable.
INTRODUCTION
Recently, lymphoblastoid cell lines established from several species of Old World non-human primates have been shown to contain herpesviruses which are related to, but distinguishable from, the Epstein-Barr virus (EBV) of man (Falk et al. I976; Gerber et al. I976; Rabin et al. I977; Rasheed et al. I977) . These EBV-related viruses can be distinguished by DNA hybridization techniques, by comparison of virus-specific nuclear antigens, and on the basis of their host range as determined by in vitro transformation. The virus capsid antigens (VCA) of these viruses show extensive cross-reactions. However, quantitative comparisons of virus EA have been difficult due to the high level of VCA relative to early antigen (EA) in producer cell lines and the fact that antigen expression is often very low. Phosphonoacetic acid (PAA) has been used to inhibit the expression of VCA in EBV-infected cells without changing the levels of EA (Summers & Klein, I976) . It has also been shown that cell lines which produce EBV show increased levels of both EA and VCA following treatment with halogenated pyrimidines (Hampar et al. 197i ). In the work reported here, chemical treatments were used to enhance the expression of EBV-related virus antigens. Such stimulations were coupled with PAA treatment to obtain high levels of EA in the relative absence of VCA and thus make comparisons of EA among EBV-retated transforming viruses feasible. The results of such comparisons are reported.
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METHODS
Cell cultures.
In these studies, the baboon 594S cells (Rabin et al. ~977) which produce EBV-related baboon herpesvirus (h. papio) were maintained on RPMI 164o medium supplemented with Io% heat-inactivated (56 °C for I h) foetal bovine serum, 2 mM-L-glutamine, 5O units/ml penicillin, and 5o/~g/ml streptomycin. Cultures were incubated at 37 °C in a humidified 5% CO2 atmosphere in air. The marmoset B95-8 cells (EBV producers; Miller & Lipman, 1973) , human Raji cells (EBV nonproducers; Pulvertaft, 1965) , orang-utan CP-8I cells (h. pongo producer; Rasheed et al. ~977) and chimpanzee Ch-888 cells (h. pan producer; Gerber et al. 1976 ) were similarly maintained. The producer status of the 594 S, B95-8, and CP-8~ cells was demonstrated by the presence of transforming virus in the supernatant fluids. The Ch-888 ceils were positive for VCA, but transforming virus was not demonstrable. Tests to determine the presence of mycoplasma in these cell lines have been negative.
Chemical stimulations. Experimental groups consisted of untreated cells, cells exposed to 5-iodo-z'-deoxyuridine (IdUrd) or PAA alone, and cells treated with IdUrd and PAA combined. Rapidly growing cells at a concentration of t x IoG/ml were exposed to IdUrd (Schwarz Mann, Orangeburg, N.Y.) at a concentration of 6o/~g/ml for 72 h, washed three times with phosphate-buffered saline, and re-fed with complete medium (Glaser et al. I973) . Cultures were harvested daily after the removal of IdUrd and assayed for virus expression. In these experiments, the day of IdUrd removal was taken as day o. Phosphonoacetic acid (Richmond Organics, Richmond, Va.) was used at a concentration of IOO/~g/ml in complete medium and was present throughout the experiment. Preliminary experiments indicated that Ioo #g/ml PAA was sufficient to reduce levels of h. papio VCA without affecting levels of cellular DNA synthesis. When used at IOO/~g/ml, PAA has been reported to inhibit the synthesis of EBV VCA but to have no effect on EA expression or cell growth (Summers & Klein, ~976) .
Sera and immunofluorescenee assays. Indirect immunofluorescence assays for crossreacting EBV VCA and EA were formed according to standard procedures using a fluorescein isothiocyanate-conjugated caprine anti-human gamma globulin reagent (Hyland Laboratories, Los Angeles, Calif.). For the detection of internal antigens, acetone-fixed (io min) smears of cells were prepared on glass slides and kept at -7o °C until used in immunofluorescence assays. Approximately 3oo cells were counted to determine the percentage of antigen-positive cells. For the determination of antibody titres, twofold dilutions were performed serially and the slides were independently scored by three individuals. Differences of a single twofold dilution were not considered significant. Two sera were used for the detection of antigen-positive cells in the 594S cell line: a baboon serum with antibodies against VCA but not EA (VCA+ serum) and with a titre of I28O was used at a I : 2o dilution; a serum with antibodies against VCA and EA (VCA+EA+ serum) with an anti-VCA titre of 320 and an anti-EA titre of 8o was used at a I : 5 dilution. For the detection of the percentage of antigen-positive marmoset, orang-utan and chimpanzee cells, a human VCA+ serum (titre of 32o) and a VCA+EA+ serum (VCA titre 2560, EA titre I6O) were used at 1:2o dilutions. Additional simian sera were supplied by Professor B. Lapin (Institute of Experimental Pathology and Therapy, Sukhummi, U.S.S.R.), Dr M. Gardner (University of Southern California, Los Angeles, Calif.) and Dr H. McClure (Emory University, Atlanta, Ga.). Human sera were obtained through Dr B. Hampar and Dr P. Levine (National Cancer Institute, National Institutes of Health, Bethesda, Md.) and human anti-R sera from Dr W. Henle (The Children's Hospital of Philadelphia, Philadelphia, Pa.). 
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RESULTS
Early antigen induction
Exposure of the 594S lymphoid cell line to IdUrd resulted in increased levels of expression of the baboon EBV-related virus. Cells were exposed to 6o #g/ml IdUrd for 72 h in the absence of PAA and then monitored for 4 successive days by immunofluorescent microscopy. In various experiments there was a variation in the level of virus expression (from I to 6%). However, when exposed to IdUrd, the cells had a marked increase in virus-associated antigens which reached peak levels I to 2 days after removal of the nucleic acid base analogue. Generally, discordant sera which contained antibodies to VCA but not to EA stained at slightly lower frequencies than did sera positive for antibodies to both EA and VCA, indicating that the expression of both antigenic groups had been stimulated. In a representative experiment (Table I) , the percentage of cells showing internal antigens increased fi'om four-to sixfold with IdUrd treatment, from 3 to 6 % in unstimulated levels to 20 to 25 % in stimulated cultures. When the 594 S cells were exposed to IdUrd (60 #g/ml for 72 h) and PAA (IOO #g/ml over the 7-day observation period), levels of EA were increased whereas VCA expression was inhibited (Table I) . Under these conditions, I8 to 2o % of the cells were EA-positive while only I to 3 % of the cells were VCA-positive. In some experiments a faint staining pattern with VCA + sera was noted in an increasing percentage of the cells toward the end of the observation period (day 4). However, this slight staining was not noted I to 2 days after removal of IdUrd when EA staining was already maximal.
Cell viability was monitored over the 7-day observation period and cultures treated with PAA alone (IOO #g/ml) showed the same growth pattern as did untreated cultures. Cultures treated with IdUrd or IdUrd and PAA combined showed a marked reduction in viability following IdUrd removal; at the end of the experimental period, the viability of both cultures was reduced by > 90 %. In controls for the experiment shown in Table I the antigen expression in untreated cultures remained at levels of 3 to 7 % for both VCA+ and VCA + EA + sera. Cultures treated with PAA alone stained at frequencies of 4 to 7 % with VCA +EA + sera, whereas staining with discordant sera showed that VCA staining had dropped to approx, o. 5 % after 7 days in culture. In other experiments when the level of antigen expression in unstimulated cells was o'5 to 1%, a significant reduction in VCA staining due to PAA alone was difficult to demonstrate; however, when IdUrd and PAA treatments were combined, EA rose to ~o to I2% of the cells, whereas VCA staining remained at < 1%.
Experiments designed to examine some of the variables involved in these stimulations showed that both EA and VCA were stimulated by exposure to IdUrd for 3 days followed by incubation in normal growth medium or by continuous exposure to IdUrd. Also, combined IdUrd/PAA treatments resulted in the selective stimulation of EA with the suppression of VCA regardless of the duration of exposure to IdUrd. Generally, IdUrd treatment for 3 days followed by incubation for 24 to 48 h in growth medium resulted in higher levels of stimulation (eightfold) than did continuous exposure to IdUrd for 4 to 5 days (threefold). When PAA was tested over the range of IO to 5oo/zg/ml, the selective stimulation of EA was shown to be maximal at Ioo/zg/ml PAA (Io-6% EA, < 1% VCA). At PAA concentrations as high as 5oo #g/ml, the degree of EA stimulation was reduced by approx. 5o%, possibly due to the inhibition of cellular growth detected at these levels.
In addition to IdUrd/PAA treatments resulting in selective stimulation of h. papio EA, similar results were obtained with EBV in B95-8 cells, with h. pongo in CP-8I ceils, and with h. pan in Ch-888 cells using concordant and discordant human sera. In these experiments, 19'9 24"6 7"2~ 22'2 * Virus antigens detected by indirect immunofluorescent microscopy using sera positive for antibodies to virus capsid antigens (VCA) or positive for antibodies to virus capsid and early antigens (VCA/EA) as described in the text. Iododeoxyuridine (IdUrd) was used. at 60/zg/ml for 3 days or in conjunction with the continuous presence of Ioo #g/ml phosphonoacetic acid (Id.Urd/PAA), ? Day after removal of nucleic acid. base analogue. VCA staining of weak intensity.
EA was detected in 7 to 8% of CP-8I cells and in 16 to I7% of B95-8 cells; in both cases VCA staining was reduced to < 1%. A modification of this technique was required for the analysis of h. pan EA in the chimpanzee Ch-888 ceils. These cells were incubated in zoo #g/ml PAA for 7 days prior to selective stimulation with IdUrd and PAA (2oo/zg/ml). This prolonged exposure to PAA was necessary to suppress VCA production and resulted in preparations with EA in 8 to Io% of the cells and a reduction in VCA staining to approx. 1%.
Comparison of early antigens
By the use of combined IdUrd and PAA treatments, EA slides were prepared from 594S, CP-8I and Ch-888 cells for the analysis of anti-EA reactivity of human and simian sera. Since the addition of PAA to the media did not affect the induction of EA in Raji cells by IdUrd, Raji cells were treated only with IdUrd (6o #g/ml for 3 days) and EBV EA preparations (without detectable VCA) were made 24 h after the removal of IdUrd. Human, baboon, orang-utah, chimpanzee, gorilla, and gibbon sera were tested at a I:Io dilution and all positive sera were then titred on each of the different EA preparations. Of the baboon sera examined, 7o% (33/47) were positive for antibodies to VCA and only I8% (6/33) of these reacted with h. papio EA. Of the nine VCA-positive orang-utan sera tested, four had antibodies against h. pongo EA and all of the I6 chimpanzee sera had antibodies against both VCA and h. pan EA. Nine human sera with anti-EBV EA reactivity were also tested.
When the anti-EA positive sera of all species were tested against EA preparations of all four virus origins, extensive cross-reactions were noted (Tables 2 and 3 )-In the comparisons of human, baboon, orang-utan, and chimpanzee sera against EA of EBV, h. papio, h. pongo and h. pan origin (Table 2) , the orang-utan and chimpanzee sera tended to titre uniformly on the various EAs. Four low titre chimpanzee sera were found, however, which failed to stain EBV EA and one of these reacted only with h. pan EA. The greatest differences existed between EBV EA and h. papio EA. Of the six h. papio EA positive baboon sera, only four reacted with EBV EA. Similarly, of the eight human sera examined which had antibodies to EBV EA, only five reacted with h. papio EA preparations. An analysis of the humanbaboon cross-reactions showed that homologous systems gave higher titres than did I6O  16o  80  40  80  40  2o  8o  4o  16o  16o  I6o   40   20  20  ~63  8O  160  160  I60  8O  20 40 40 * EA selectively stimulated by IdUrd/PAA treatments t Reciprocal of dilution. Not determined.
as described in the text.
heterologous systems. A similar effect was noted in that human or baboon sera of equal titres showed more intense fluorescent staining when tested on the homologous source of EA. Testing of sera from those species of apes from which EBV-related viruses have not been isolated also revealed anti-EA reactivities (Table 3) . Sixty-seven per cent (8/I2) of gorilla and zo% (2/IO) of gibbon VCA-positive sera were found to contain cross-reacting antibodies to EA. These sera titred uniformly on the various EAs, but two gorilla sera showed a slightly higher reading on h. pan and h. pongo EAs. and D (diffuse), could be distinguished on the basis of cellular localization and sensitivity to various fixation procedures. In the present study, the staining pattern in EA positive cells was that characteristic of the D form of EA, with antigen being detected in both the nucleus and the cytoplasm. In human sera, the main anti-EA response is against the D component with the exception of Burkitt's lymphoma (BL), where anti-R is often the only antibody to the EA complex present (Henle et al. I97I) . Since all the simian sera tested gave only a D staining pattern, we utilized anti-R sera (supplied by Dr W. Henle) from BL patients to test for the presence of an R form of EA associated with the EBV-related viruses of nonhuman primates. Using these five human sera, an R component could be demonstrated in h. papio-, h. pongo-, and h. pan-infected cells. As is true for EBV, the R component was found in the cytoplasm and tended to present an aggregated appearance. The R and D reactive cells were found in approx, equal percentages in all the cell lines tested and for h. papio and EBV the R form was sensitive to methanol fixation whereas the D form was not. An examination of the titres of these BL sera on the various EAs revealed that, like the anti-D reactivity, the greatest differences were found between EBV and h. papio forms of EA. All five of the sera tested gave equal titres on EBV, h. pongo, and h. pan forms of EA (within a single twofold dilution). However, three of these sera gave significantly lower titres with h. papio EA.
DISCUSSION
These experiments demonstrated that treatments combining IdUrd and PAA resulted in the selective stimulation of EA in lymphoblastoid cell lines which produce EBV-related viruses. The marked increase in the frequency of EA-positive cells in the relative absence of VCA has allowed for the comparison of EA in related viruses. The results of this analysis suggest that the EAs of these viruses, while related to each other, are distinguishable, with the greatest differences being between EBV and h. papio. The differences were indicated by ability to select sera which had positive reactivity only with the homologous antigen and by differences in homologous and heterologous titres in certain cross-reacting sera. These differences were also demonstrable for both the R and D components of EA and suggest that EBV-related viruses can be distinguished by their early antigens as well as by comparisons of virus-specific nuclear antigens and by DNA hybridization techniques. Utilizing
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3oi the comparisons of EA as presented in this study, it can be seen that EBV and h. papio are the most dissimilar and that h. pongo and h. pan occupy intermediate positions. This finding is in agreement with results of a preliminary study which compared the nuclear antigens of these viruses (Rabin et al. I978) and where the results indicated that EBV was more related to h. pongo than to h. pan, with h. papio being the most divergent. Although these EBV-related viruses can be distinguished serologically, determination of the actual nature and quantity of these differences must await the availability of purified antigens and the development of quantitative immunological assays.
